Cargando…
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136062/ https://www.ncbi.nlm.nih.gov/pubmed/35647075 http://dx.doi.org/10.3389/fcvm.2022.887236 |
| _version_ | 1784714093991559168 |
|---|---|
| author | Iborra-Egea, Oriol Aimo, Alberto Bayes-Genis, Antoni |
| author_facet | Iborra-Egea, Oriol Aimo, Alberto Bayes-Genis, Antoni |
| author_sort | Iborra-Egea, Oriol |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9136062 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91360622022-05-28 Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction Iborra-Egea, Oriol Aimo, Alberto Bayes-Genis, Antoni Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2022-05-13 /pmc/articles/PMC9136062/ /pubmed/35647075 http://dx.doi.org/10.3389/fcvm.2022.887236 Text en Copyright © 2022 Iborra-Egea, Aimo and Bayes-Genis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cardiovascular Medicine Iborra-Egea, Oriol Aimo, Alberto Bayes-Genis, Antoni Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction |
| title | Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction |
| title_full | Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction |
| title_fullStr | Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction |
| title_full_unstemmed | Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction |
| title_short | Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction |
| title_sort | different effects on protein expression of cdr132l, an antisense inhibitor of mir-132, and standard therapies for myocardial infarction |
| topic | Cardiovascular Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136062/ https://www.ncbi.nlm.nih.gov/pubmed/35647075 http://dx.doi.org/10.3389/fcvm.2022.887236 |
| work_keys_str_mv | AT iborraegeaoriol differenteffectsonproteinexpressionofcdr132lanantisenseinhibitorofmir132andstandardtherapiesformyocardialinfarction AT aimoalberto differenteffectsonproteinexpressionofcdr132lanantisenseinhibitorofmir132andstandardtherapiesformyocardialinfarction AT bayesgenisantoni differenteffectsonproteinexpressionofcdr132lanantisenseinhibitorofmir132andstandardtherapiesformyocardialinfarction |